Advertisement

Artificial Tears Solution Drug Facts | LiquiTears

16:30 EDT 23rd May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Polyvinyl Alcohol 1.4%

Lubricant

When using this product  

Stop use and ask a doctor if

If swallowed, get medical help or contact a Poison Control Center right away

 

dibasic sodium phosphate, edetate disodium, monobasic sodium phosphate, sodium chloride,

purified water. Phosphoric acid and/or sodium hydroxide may be added to adjust pH. PRESERVATIVE ADDED: benzalkonium chloride 0.01%

Serious side effects associated with use of this product may be reported to 1800-323-0000

*MAJOR LIQUITEARS IS NOT MANUFACTURED OR DISTRIBUTED BY ALLERGAN, INC. OWNER OF THE REGISTERED TRADEMARK, LIQUIFILM TEARS®.

MAJOR®

NDC 0904-5017-35

LiquiTears

Polyvinyl Alcohol 1.4%

Lubricant Eye Drops (Sterile)

Relieves Burning due to Dryness of the Eye

Compare to Active Ingredient of Liquifilm Tears®*

1/2 FL. OZ. (15 mL)

IMAGE d639b093-9907-4b20-a3a1-c19bfcedb5d7-01.jpg

Manufacturer

MAJOR PHARMACEUTICALS

Active Ingredients

Source

Drugs and Medications [0 Results]

None

Clinical Trials [ 1 Associated Clinical Trials listed on BioPortfolio]

Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract

This study will evaluate the safety and efficacy of three doses of C-KAD Ophthalmic Solution in patients with loss of visual function due to age-related nuclear cataract

PubMed Articles [0 Results]

None

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement